Many cofactors bind the hormone-activated estrogen receptor (ER), yet the s
pecific regulators of endogenous ER-mediated gene transcription are unknown
. Using chromatin immunoprecipitation (ChIP), we find that ER and a number
of coactivators rapidly associate with estrogen responsive promoters follow
ing estrogen treatment in a cyclic fashion that is not predicted by current
models of hormone activation. Cycles of ER complex assembly are followed b
y transcription. In contrast, the anti-estrogen tamoxifen (TAM) recruits co
repressors but not coactivators. Using a genetic approach, we show that rec
ruitment of the p160 class of coactivators is sufficient for gene activatio
n and for the growth stimulatory actions of estrogen in breast cancer suppo
rting a model in which ER cofactors play unique roles in estrogen signaling
.